Amprenavir

In the US, Amprenavir (amprenavir systemic) is a member of the drug class protease inhibitors and is used to treat HIV Infection.

US matches:

• Amprenavir


• Amprenavir Solution

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

J05AE05

CAS registry number (Chemical Abstracts Service)

0161814-49-9

Chemical Formula

C25-H35-N3-O6-S

Molecular Weight

505

Therapeutic Category

Antiviral agent, HIV protease inhibitor

Chemical Name

Carbamic acid, (3-(((4-aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-(- phenylmethyl)propyl)-, tetrahydro-3-furanyl ester, (3S-(3R*(1S*,2R*)))-

Foreign Names

• Amprenavirum (Latin)
• Amprenavir (German)
• Amprénavir (French)
• Amprenavir (Spanish)

Generic Names

• Amprenavir (OS: JAN, BAN, USAN)
• Amprénavir (OS: DCF)
• 141 W 94 (IS)
• KVX 478 (IS)
• VX 478 (IS)

Brand Names

• Agenerase
  Glaxo Group, Bulgaria; Glaxo Group, Luxembourg; Glaxo SmithKline, Spain; Glaxo Wellcome, Portugal; GlaxoSmithKline, Argentina; GlaxoSmithKline, Australia; GlaxoSmithKline, Bahrain; GlaxoSmithKline, Brazil; GlaxoSmithKline, Canada; GlaxoSmithKline, Chile; GlaxoSmithKline, Greece; GlaxoSmithKline, Israel; GlaxoSmithKline, Iceland; GlaxoSmithKline, Mexico; GlaxoSmithKline, Netherlands; GlaxoSmithKline, Romania; GlaxoSmithKline, Slovenia; GlaxoSmithKline, Slovakia; GlaxoSmithKline, Turkey; GlaxoSmithKline, United States; GlaxoSmithKline, Venezuela

International Drug Name Search

Glossary

BAN	British Approved Name
DCF	Dénomination Commune Française
IS	Inofficial Synonym
JAN	Japanese Accepted Name
OS	Official Synonym
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.